(Reuters) – Canadian drugmaker Valeant Pharmaceuticals International Inc VRX.TO VRX.N raised the cash component of its unsolicited offer for Botox-maker Allergan Inc AGN.N, valuing the U.S. firm at $49.44 billion and ratcheting up pressure on the target company.
Valeant’s sweetened...
Valeant injects cash into bid for botox maker
Wednesday, May 28, 2014
Valeant injects cash into bid for botox maker
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment